Yes, that 1.7m buy at 15.5c is interesting. See if it stays. Either way, if its oversubscribed, it might but a nice supporting floor on the price. Wait and see.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025